6th CKD Drug Development Summit: Countdown Begins

The asset is indicated to treat paroxysmal nocturnal haemoglobinuria. Credit: MMC-Rodenbusch / Shutterstock. Samsung Bioepis has announced the approval of its EPYSQLI (eculizumab-aagh) biologics licence

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions, re­calls and more. VBI Vac­cines is sell­ing its HBV

The link between childhood blood pressure (BP) and adult atherosclerosis appeared stable going all the way back to infancy, suggesting that efforts to prevent arterial